Search Count: 33
 |
Discovery Of An Orally Bioavailable Reversible Covalent Sars-Cov-2 Mpro Inhibitor With Pan-Coronavirus Activity
Organism: Severe acute respiratory syndrome coronavirus 2, Synthetic construct
Method: X-RAY DIFFRACTION Release Date: 2025-08-20 Classification: HYDROLASE/INHIBOTOR Ligands: A1L7M |
 |
Discovery Of An Orally Bioavailable Reversible Covalent Sars-Cov-2 Mpro Inhibitor With Pan-Coronavirus Activity
Organism: Severe acute respiratory syndrome coronavirus 2, Synthetic construct
Method: X-RAY DIFFRACTION Release Date: 2025-08-20 Classification: HYDROLASE/INHIBITOR |
 |
Discovery Of An Orally Bioavailable Reversible Covalent Sars-Cov-2 Mpro Inhibitor With Pan-Coronavirus Activity
Organism: Severe acute respiratory syndrome coronavirus 2, Synthetic construct
Method: X-RAY DIFFRACTION Release Date: 2025-08-20 Classification: HYDROLASE/INHIBITOR |
 |
Discovery Of An Orally Bioavailable Reversible Covalent Sars-Cov-2 Mpro Inhibitor With Pan-Coronavirus Activity
Organism: Severe acute respiratory syndrome coronavirus 2, Synthetic construct
Method: X-RAY DIFFRACTION Release Date: 2025-08-20 Classification: HYDROLASE/INHIBITOR Ligands: A1L7M |
 |
Discovery Of An Orally Bioavailable Reversible Covalent Sars-Cov-2 Mpro Inhibitor With Pan-Coronavirus Activity
Organism: Severe acute respiratory syndrome coronavirus 2, Synthetic construct
Method: X-RAY DIFFRACTION Release Date: 2025-08-20 Classification: HYDROLASE/INHIBITOR Ligands: A1L7M |
 |
Organism: Mus musculus, Saccharomyces cerevisiae
Method: ELECTRON MICROSCOPY Release Date: 2023-06-21 Classification: TRANSLOCASE/IMMUNE SYSTEM Ligands: CDL, PTY |
 |
Organism: Saccharomyces cerevisiae, Mus musculus
Method: ELECTRON MICROSCOPY Release Date: 2023-06-21 Classification: TRANSLOCASE Ligands: CDL, PTY |
 |
Organism: Homo sapiens
Method: ELECTRON MICROSCOPY Release Date: 2021-11-10 Classification: TRANSPORT PROTEIN Ligands: BEF, MG, Y01, LMT |
 |
Organism: Homo sapiens
Method: ELECTRON MICROSCOPY Release Date: 2021-11-10 Classification: TRANSPORT PROTEIN Ligands: ALF, MG, SPM, Y01, PC1, LMT |
 |
Organism: Homo sapiens
Method: ELECTRON MICROSCOPY Release Date: 2021-11-10 Classification: TRANSPORT PROTEIN Ligands: ADP, ALF, MG, Y01 |
 |
Organism: Homo sapiens
Method: ELECTRON MICROSCOPY Release Date: 2021-11-10 Classification: TRANSPORT PROTEIN Ligands: ATP, MG, Y01 |
 |
Cryo-Em Structure Of Atp13A2 D458N/D962N Mutant In The E1-Apo State, Conformation 1
Organism: Homo sapiens
Method: ELECTRON MICROSCOPY Release Date: 2021-11-10 Classification: TRANSPORT PROTEIN |
 |
Cryo-Em Structure Of Atp13A2 D458N/D962N Mutant In The E1-Apo State, Conformation 2
Organism: Homo sapiens
Method: ELECTRON MICROSCOPY Release Date: 2021-11-10 Classification: TRANSPORT PROTEIN |
 |
Cryo-Em Structure Of Atp13A2 D458N/D962N Mutant In The Alf-Bound E1P-Like State
Organism: Homo sapiens
Method: ELECTRON MICROSCOPY Release Date: 2021-11-10 Classification: TRANSPORT PROTEIN Ligands: ALF, MG, Y01 |
 |
Organism: Homo sapiens
Method: ELECTRON MICROSCOPY Release Date: 2021-11-10 Classification: TRANSPORT PROTEIN Ligands: PO4, MG, SPM, Y01, PC1, LMT |
 |
Fragment-Based Lead Discovery Of Indazole-Based Compounds As Axl Kinase Inhibitors
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:3.15 Å Release Date: 2021-10-13 Classification: TRANSFERASE/TRANSFERASE INHIBITOR Ligands: E56 |
 |
Organism: Saccharomyces cerevisiae (strain atcc 204508 / s288c)
Method: ELECTRON MICROSCOPY Release Date: 2020-09-23 Classification: TRANSPORT PROTEIN Ligands: LMT |
 |
Organism: Saccharomyces cerevisiae (strain atcc 204508 / s288c)
Method: ELECTRON MICROSCOPY Release Date: 2020-09-23 Classification: TRANSPORT PROTEIN Ligands: ACP, MG |
 |
Organism: Saccharomyces cerevisiae (strain atcc 204508 / s288c)
Method: ELECTRON MICROSCOPY Release Date: 2020-09-23 Classification: TRANSPORT PROTEIN Ligands: MG, ALF |
 |
Organism: Saccharomyces cerevisiae (strain atcc 204508 / s288c)
Method: ELECTRON MICROSCOPY Release Date: 2020-09-23 Classification: TRANSPORT PROTEIN Ligands: BEF, MG |